Logo image of CBLU.CA

CLEAR BLUE TECHNOLOGIES INTE (CBLU.CA) Stock Fundamental Analysis

TSX-V:CBLU - TSX Venture Exchange - CA18453C1077 - Common Stock - Currency: CAD

0.025  0 (0%)

Fundamental Rating

1

CBLU gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 40 industry peers in the Independent Power and Renewable Electricity Producers industry. Both the profitability and financial health of CBLU have multiple concerns. CBLU does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CBLU had negative earnings in the past year.
CBLU had a negative operating cash flow in the past year.
In the past 5 years CBLU always reported negative net income.
In the past 5 years CBLU always reported negative operating cash flow.
CBLU.CA Yearly Net Income VS EBIT VS OCF VS FCFCBLU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

CBLU has a Return On Assets of -40.16%. This is amonst the worse of the industry: CBLU underperforms 92.31% of its industry peers.
Industry RankSector Rank
ROA -40.16%
ROE N/A
ROIC N/A
ROA(3y)-38.6%
ROA(5y)-79.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBLU.CA Yearly ROA, ROE, ROICCBLU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -10K -20K

1.3 Margins

The Gross Margin of CBLU (45.77%) is worse than 80.77% of its industry peers.
CBLU's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CBLU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.69%
GM growth 5Y29.78%
CBLU.CA Yearly Profit, Operating, Gross MarginsCBLU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

1

2. Health

2.1 Basic Checks

CBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CBLU has more shares outstanding
The number of shares outstanding for CBLU has been increased compared to 5 years ago.
Compared to 1 year ago, CBLU has a worse debt to assets ratio.
CBLU.CA Yearly Shares OutstandingCBLU.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CBLU.CA Yearly Total Debt VS Total AssetsCBLU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

CBLU has an Altman-Z score of -4.28. This is a bad value and indicates that CBLU is not financially healthy and even has some risk of bankruptcy.
CBLU has a Altman-Z score of -4.28. This is in the lower half of the industry: CBLU underperforms 65.38% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -4.28
ROIC/WACCN/A
WACC6.26%
CBLU.CA Yearly LT Debt VS Equity VS FCFCBLU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M

2.3 Liquidity

A Current Ratio of 1.16 indicates that CBLU should not have too much problems paying its short term obligations.
CBLU has a better Current ratio (1.16) than 69.23% of its industry peers.
A Quick Ratio of 0.47 indicates that CBLU may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.47, CBLU is doing worse than 88.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 0.47
CBLU.CA Yearly Current Assets VS Current LiabilitesCBLU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

1

3. Growth

3.1 Past

CBLU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.43%.
The Revenue has grown by 24.29% in the past year. This is a very strong growth!
The Revenue has been decreasing by -6.50% on average over the past years.
EPS 1Y (TTM)-17.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-179.69%
Revenue 1Y (TTM)24.29%
Revenue growth 3Y-12.43%
Revenue growth 5Y-6.5%
Sales Q2Q%-83.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CBLU.CA Yearly Revenue VS EstimatesCBLU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
CBLU.CA Yearly EPS VS EstimatesCBLU.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

CBLU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBLU.CA Price Earnings VS Forward Price EarningsCBLU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBLU.CA Per share dataCBLU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.01 -0.02 -0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CBLU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLEAR BLUE TECHNOLOGIES INTE

TSX-V:CBLU (2/21/2025, 7:00:00 PM)

0.025

0 (0%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)11-29 2024-11-29
Earnings (Next)05-26 2025-05-26
Inst Owners0.1%
Inst Owner ChangeN/A
Ins Owners4.84%
Ins Owner ChangeN/A
Market Cap11.58M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.69
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.01
BVpS-0.02
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.16%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.77%
FCFM N/A
ROA(3y)-38.6%
ROA(5y)-79.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.69%
GM growth 5Y29.78%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 398.53%
Cap/Sales 76.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.16
Quick Ratio 0.47
Altman-Z -4.28
F-Score4
WACC6.26%
ROIC/WACCN/A
Cap/Depr(3y)1014.71%
Cap/Depr(5y)616.01%
Cap/Sales(3y)61.64%
Cap/Sales(5y)37.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-179.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.29%
Revenue growth 3Y-12.43%
Revenue growth 5Y-6.5%
Sales Q2Q%-83.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y60.51%
OCF growth 3YN/A
OCF growth 5YN/A